These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 12873172)
41. The Role of Gynecological Cytology in the Era of Molecular Testing. Longatto-Filho A Acta Cytol; 2016; 60(6):499-500. PubMed ID: 27829246 [No Abstract] [Full Text] [Related]
42. Consensus panel on cervical cancer highlights the HPV connection. McNeil C J Natl Cancer Inst; 1996 May; 88(9):575. PubMed ID: 8609653 [No Abstract] [Full Text] [Related]
43. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. Villa LL; Sichero L; Rahal P; Caballero O; Ferenczy A; Rohan T; Franco EL J Gen Virol; 2000 Dec; 81(Pt 12):2959-2968. PubMed ID: 11086127 [TBL] [Abstract][Full Text] [Related]
44. Human papillomavirus. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial. Richart RM; Masood S; Syrjänen KJ; Vassilakos P; Kaufman RH; Meisels A; Olszewski WT; Sakamoto A; Stoler MH; Vooijs GP; Wilbur DC Acta Cytol; 1998; 42(1):50-8. PubMed ID: 9479323 [TBL] [Abstract][Full Text] [Related]
45. Relation between infection with human papilloma viruses and expression of p21 and p53 oncoproteins in patients with cancer of the uterine cervix. Bar JK; Markowska J; Harlozińska A; Sedlaczek P; Nowak M; Roszak A Eur J Gynaecol Oncol; 1996; 17(4):283-5. PubMed ID: 8856306 [TBL] [Abstract][Full Text] [Related]
47. Differential expression of the human homologue of drosophila discs large oncosuppressor in histologic samples from human papillomavirus-associated lesions as a marker for progression to malignancy. Cavatorta AL; Fumero G; Chouhy D; Aguirre R; Nocito AL; Giri AA; Banks L; Gardiol D Int J Cancer; 2004 Sep; 111(3):373-80. PubMed ID: 15221964 [TBL] [Abstract][Full Text] [Related]
48. Human papillomavirus and disease status following therapy for cervical cancer. Unger ER; Vernon SD; Nisenbaum R; Thoms WW; Spann C; Miller DL; Lee DR; Horowitz IR; Icenogle JP; Reeves WC Clin Infect Dis; 1998 Feb; 26(2):373-8. PubMed ID: 9502457 [TBL] [Abstract][Full Text] [Related]
49. Detection of human papillomavirus in warty carcinoma of the uterine cervix: comparison of immunohistochemistry, in situ hybridization and in situ polymerase chain reaction methods. Cho NH; Joo HJ; Ahn HJ; Jung WH; Lee KG Pathol Res Pract; 1998; 194(10):713-20. PubMed ID: 9820868 [TBL] [Abstract][Full Text] [Related]
50. Human papillomavirus in carcinogenesis of cervical cancer. de Silva NR; Mendis L; Perera N Ceylon Med J; 1999 Mar; 44(1):45-7. PubMed ID: 10643100 [No Abstract] [Full Text] [Related]
51. Positive high-risk HPV test with negative cytology--a conundrum and blessing of our latest technology. Harper DM; Groner JA Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):10-1. PubMed ID: 24420983 [No Abstract] [Full Text] [Related]
52. Detection of human papillomavirus DNA in genital lesions by enzymatic in situ hybridization with Fast Red and laser scanning confocal microscopy. Lizard G; Chignol MC; Roignot P; Souchier C; Chardonnet Y; Schmitt D Histochem J; 1997 Jul; 29(7):545-54. PubMed ID: 9279557 [TBL] [Abstract][Full Text] [Related]
53. Detection of HPV DNA in archival, Papanicolaou-stained cervical smears using PCR. Lehmann U; Poche-de Vos F; Poche-Blohm I Acta Cytol; 1998; 42(4):1051-3. PubMed ID: 9684606 [No Abstract] [Full Text] [Related]
54. Human papillomavirus detected in a colonic metastasis of cervical adenocarcinoma. Damin AP; Agnes G; Tarta C; Contu PC; Ghezzi TL; Kliemann LM; Damin DC Tech Coloproctol; 2014 May; 18(5):515-6. PubMed ID: 23549714 [No Abstract] [Full Text] [Related]
55. Successfully integrating human papillomavirus testing into your practice. Lozano R Arch Pathol Lab Med; 2003 Aug; 127(8):991-4. PubMed ID: 12873172 [TBL] [Abstract][Full Text] [Related]
57. Delivering human papillomavirus testing to the public: one patient advocate's perspective. Roach N Arch Pathol Lab Med; 2003 Aug; 127(8):995-6. PubMed ID: 12873173 [TBL] [Abstract][Full Text] [Related]
58. Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs. Lörincz AT; Richart RM Arch Pathol Lab Med; 2003 Aug; 127(8):959-68. PubMed ID: 12873167 [TBL] [Abstract][Full Text] [Related]
59. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136 [TBL] [Abstract][Full Text] [Related]
60. Human papillomavirus testing--are you ready for a new era in cervical cancer screening? Davey DD; Zarbo RJ Arch Pathol Lab Med; 2003 Aug; 127(8):927-9. PubMed ID: 12873162 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]